Pd46-04 Synchronous Management of Urethral Stricture Disease and Penile Prosthesis Implantation: A Case Series

You have accessJournal of UrologySexual Function/Dysfunction: Surgical Therapy I (PD46)1 May 2024PD46-04 SYNCHRONOUS MANAGEMENT OF URETHRAL STRICTURE DISEASE AND PENILE PROSTHESIS IMPLANTATION: A CASE SERIES Ankith P. Maremanda, William S. Du Comb, Mark N. Alshak, Harjit S. Nalwa, Corey Able, and Arthur Burnett Ankith P. MaremandaAnkith P. Maremanda , William S. Du CombWilliam S. Du Comb , Mark N. AlshakMark N. Alshak , Harjit S. NalwaHarjit S. Nalwa , Corey AbleCorey Able , and Arthur BurnettArthur Burnett View All Author Informationhttps://doi.org/10.1097/01.JU.0001008900.49567.2e.04AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Urethral stricture disease (USD) is found in approximately 0.9% of all men in developed countries. As the prevalence of USD increases, surgeons may encounter USD at increasing rates during penile prosthesis (PP) implantation. There is currently limited data to evaluate the outcomes of treating USD concurrently to PP implantation. Our study aims to monitor the outcomes of PP placement in the event of USD. METHODS: A retrospective IRB-approved chart review (IRB00205900) was performed for patients that had undergone PP implantation and incidentally found USD at the time of procedure from 2009 to 2023. Inability to pass a urethral catheter arose suspicion for USD. Cases that could proceed as planned were classified as "completed," while cases that could not proceed were classified as "aborted." Stricture location and size, procedural information, demographic data, and comorbidities were noted. Successful management was defined as the absence of complications requiring explantation, including device infection, erosion, or failure, within 90 days of the procedure. Recurrence of stricture was defined as the presence or worsening of obstructive lower urinary symptoms at any post-operative follow-up visits. RESULTS: Of the 2375 PP implantations performed from 2009 to 2023, twenty-four cases were identified in which incidental USD was found. Out of twenty-four patients, eighteen (75%) had IPPs implanted, while six (25%) had their procedures aborted. Of the eighteen patients, thirteen (13/18, 72.2%) underwent urethral dilation with Amplatz dilators, three (3/18, 16.7%) had passive dilation with a 16F flexible cystoscope, and two (2/18, 11.1%) had a DVIU. Within 90 days after the procedure, only one patient presented with urinary retention four days after the procedure (1/18, 5.6%). No PP infections occurred within 90 days. Only one patient (1/18, 5.6%) had their device explanted due to extrusion five years after the procedure. One patient had a recurrence of their stricture after four years (1/18, 5.6%). CONCLUSIONS: This case study of patients receiving synchronous USD management and PP implantation yielded high success and low complication rates within 90 days. While a large, multi-institutional study should be performed, our study displays promising results and creates a framework that surgeons may follow. Download PPT Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e974 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Ankith P. Maremanda More articles by this author William S. Du Comb More articles by this author Mark N. Alshak More articles by this author Harjit S. Nalwa More articles by this author Corey Able More articles by this author Arthur Burnett More articles by this author Expand All Advertisement PDF downloadLoading ...